Galderma bags Two Prestigious Marketing Awards

Mumbai, 19th October 2015 - Galderma India’s unique and advanced depigmenting and skin lightening cream BI-LUMA has won the prestigious Dr. H.R. Nanji Memorial OPPI Marketing Excellence Award for the Best ‘New Pharmaceutical Introduction’. This award is in recognition towards Galderma’s relentless commitment towards Dermatology benefiting many patients across the country.

The Organisation of Pharmaceutical Producers of India (OPPI) represents the research-based pharmaceutical companies in India and is committed to supporting India’s healthcare objectives and engaging with the Government and other stakeholders to find sustainable healthcare solutions.

The award was conferred to Galderma by Dr. V. K. Subburaj, Secretary, Department of Pharmaceuticals during OPPI’s 49th Annual General Meeting and Golden Jubilee celebration held in Mumbai. Other dignitaries at the event included Hon’ble Governor of Maharashtra Shri. C V Rao who was the Chief Guest, and Dr Jagdish Prasad, Directorate General of Health Services (DGHS) who was the Guest of Honour at the event.

Last week, AIOCD AWACS, a pharmaceutical market research organization, also conferred BI-LUMA with their Gold award for Marketing Excellence under ‘New Introduction Category’ in Mumbai. This back-to-back recognition truly showcases BI-LUMA’s innovative formulation and differential strategy.

Galderma, part of Nestlé Skin Health and whose innovative dermatology medical solutions are recommended by HCPs across the world, had launched BI-LUMA last year and it has already won the hearts of many dermatologists and the consumers across the country. BI-LUMA’s unique formulation is the dermatologically tested and clinically proven solution for dark patches and unevenness of the skin that surface due to various hyperpigmentary disorders. - BI-LUMA cream is scientifically formulated to provide skin with an even tone & glow.

“As per the latest IMS audit report, the category of Demelanising agents in India is pegged at Rs. 450 crores and is one of the fastest growing categories in overall dermatology market. Indians generally suffer from various hyperpigmentary disorders such as melasma and post-inflammatory hyperpigmentation (PIH) that result in uneven skin tone. At Galderma, we are committed to the future of dermatology by offering unique and innovative medical solutions to millions of Indians and thereby improving their quality of life. BI-LUMA’s unique product attributes, cosmetic elegance and aesthetic appeal has benefitted many consumers across the country. Now, with this overwhelming success of an indigenous project of BI-LUMA, we are confident to expand its presence in other countries and achieve many more milestones in future”, said Mr. G Sathya Narayanan, MD, Galderma South Asia.

Read the rest of this entry

Galderma launches BI-LUMA

Galderma launches BI-LUMA, a safe and effective skincare solution, in India

• Blended with natural ingredients, BI-LUMA is scientifically formulated to restore the skin’s even tone and glow
• BI-LUMA is a rich creamy, non-greasy and steroid-free formulation that spreads easily on the skin

New Delhi: Galderma, one of the world’s leading companies focused on dermatology and skin health, has launched in India its new clinically-tested skin lightening cream BI-LUMA, a unique, non-greasy and steroid free formulation specially engineered for restoring even skin tone and glow.

The cream introduced by Galderma, whose path-breaking products are the preferred choice world over, is very effective for providing relief from stubborn dark patches and unevenness that surface due to various hyperpigmentary disorders.

The company has roped in dazzling Bollywood star and model Hazel Keech as its brand ambassador. The product contains natural skin lightening ingredients, along with UVB filter and anti-oxidants which act synergistically to block melanin hypersynthesis pathways and distribution, at various stages.

As per latest reports from IMS, India’s hyperpigmentation market is valued to be Rs. 391 crores and is growing at 19% per year. With its flagship brand Cetaphil, Galderma is present in the Indian market with its prescription-based products. Its aesthetic range of Restylane products, especially skin boosters, have been drawing encouraging response in the country.

“In India, people generally suffer from various hyperpigmentary disorders such as melasma and post-inflammatory hyperpigmentation (PIH) that result in an uneven skin tone. We are present in the Indian market for the last 15 years and have been introducing products which are unique and reliable. Like all our dermatology solutions, we are confident that our latest product will emerge as an effective dermatological solution for patients suffering from hyperpigmentary disorders and restore their skin with an even tone and glow,” says Mr G Sathya Narayanan, Managing Director, Galderma India.

BI-LUMA offers a unique, three-way solution – it corrects melanin hyper-synthesis and distribution; boosts anti-oxidant and anti-inflammatory defense; and protects the skin from UVB radiation.

BI-LUMA is available at chemist and drug stores across India. The usage of BI-LUMA cream is simple and is advised to be applied twice daily. The product spreads easily on the skin and shows visible results within four weeks.

Read the rest of this entry